Table 5. . Gender-based association analyses of utilization scores in the dominant model.
Single-nucleotide polymorphism | Sex | Total subjects | IRR (97.5% CI) | p-value |
---|---|---|---|---|
rs5638 | M | 45 | 1.1 (0.49–2.47) | 0.819 |
F | 84 | 0.74 (0.48–1.15) | 0.171 | |
rs2934965 | M | 45 | 0.51 (0.19–1.51) | 0.187 |
F | 86 | 0.58 (0.33–1.04) | 0.060 | |
rs876493 | M | 43 | 1.1 (0.53–2.28) | 0.803 |
F | 82 | 0.56 (0.38–0.82) | 0.003* | |
rs2941523 | M | 45 | 0.62 (0.24–1.76) | 0.285 |
F | 86 | 0.76 (0.50–1.17) | 0.203 |
Regression models are adjusted for covariates (age, sex, and sickle cell type).
*p-values < 0.05.
F: Female; IRR: Incidence risk ratio; M: Male.